Literature DB >> 25523972

The dynamic changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European region: results of a second structured survey.

H Grundmann1, L M Schouls, D M Aanensen, G N Pluister, A Tami, M Chlebowicz, C Glasner, A J Sabat, K Weist, O Heuer, A W Friedrich.   

Abstract

Staphylococcus aureus is one of the most important human pathogens and meticillin-resistant S. aureus (MRSA) presents a major cause of healthcare- and community-acquired infections. This study investigated the spatial and temporal changes of S. aureus causing bacteraemia in Europe over a five-year interval and explored the possibility of integrating pathogen-based typing data with epidemiological and clinical information at a European level. Between January 2011 and July 2011, 350 laboratories serving 453 hospitals in 25 countries collected 3,753 isolates (meticillin-sensitive S. aureus (MSSA) and MRSA) from patients with S. aureus bloodstream infections. All isolates were sent to the national staphylococcal reference laboratories and characterised by quality-controlled spa typing. Data were uploaded to an interactive web-based mapping tool. A wide geographical distribution of spa types was found, with some prevalent in all European countries. MSSA was more diverse than MRSA. MRSA differed considerably between countries with major international clones expanding or receding when compared to a 2006 survey. We provide evidence that a network approach of decentralised typing and visualisation of aggregated data using an interactive mapping tool can provide important information on the dynamics of S. aureus populations such as early signalling of emerging strains, cross-border spread and importation by travel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25523972     DOI: 10.2807/1560-7917.es2014.19.49.20987

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  45 in total

1.  Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study.

Authors:  R San-Juan; D Pérez-Montarelo; E Viedma; A Lalueza; J Fortún; E Loza; M Pujol; C Ardanuy; I Morales; M de Cueto; E Resino-Foz; M A Morales-Cartagena; M Fernández-Ruiz; A Rico; M P Romero; M Fernández de Mera; F López-Medrano; M Á Orellana; J M Aguado; F Chaves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-05       Impact factor: 3.267

2.  Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.

Authors:  Kwaku Kyei-Baffour; Haroon Mohammad; Mohamed N Seleem; Mingji Dai
Journal:  Bioorg Med Chem       Date:  2019-03-19       Impact factor: 3.641

3.  Spa type distribution in MRSA and MSSA bacteremias and association of spa clonal complexes with the clinical characteristics of bacteremia.

Authors:  Elina Jokinen; Laura Lindholm; Reetta Huttunen; Heini Huhtala; Risto Vuento; Jaana Vuopio; Jaana Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-10       Impact factor: 3.267

4.  Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers.

Authors:  N Piper Jenks; M Pardos de la Gandara; B M D'Orazio; J Correa da Rosa; R G Kost; C Khalida; K S Vasquez; C Coffran; M Pastagia; T H Evering; C Parola; T Urban; S Salvato; F Barsanti; B S Coller; J N Tobin
Journal:  Travel Med Infect Dis       Date:  2016-10-20       Impact factor: 6.211

5.  MALDI-TOF bacterial subtyping to detect antibiotic resistance.

Authors:  Miriam Cordovana; Arthur Boniface Pranada; Simone Ambretti; Markus Kostrzewa
Journal:  Clin Mass Spectrom       Date:  2019-06-14

6.  Risk Factors of Recurrent Infection in Patients with Staphylococcus aureus Bacteremia: a Competing Risk Analysis.

Authors:  Seongman Bae; Eun Sil Kim; Hee Seung Kim; Eunmi Yang; Hyemin Chung; Yun Woo Lee; Jiwon Jung; Min Jae Kim; Yong Pil Chong; Sung-Han Kim; Sang-Ho Choi; Sang-Oh Lee; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2022-06-28       Impact factor: 5.938

7.  An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection.

Authors:  Haroon Mohammad; Kwaku Kyei-Baffour; Nader S Abutaleb; Mingji Dai; Mohamed N Seleem
Journal:  J Glob Antimicrob Resist       Date:  2019-04-30       Impact factor: 4.035

Review 8.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

9.  Enhanced Tracking of Nosocomial Transmission of Endemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Type IV Isolates among Patients and Environmental Sites by Use of Whole-Genome Sequencing.

Authors:  Peter M Kinnevey; Anna C Shore; Micheál Mac Aogáin; Eilish Creamer; Gráinne I Brennan; Hilary Humphreys; Thomas R Rogers; Brian O'Connell; David C Coleman
Journal:  J Clin Microbiol       Date:  2015-11-18       Impact factor: 5.948

10.  First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone.

Authors:  Anna C Shore; Alexandros Lazaris; Peter M Kinnevey; Orla M Brennan; Gráinne I Brennan; Brian O'Connell; Andrea T Feßler; Stefan Schwarz; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.